U.S. Food and Drug Administration
Repligen Corporation (NASDAQ: RGEN) may be the biotech implosion of the day if the volume starts to catch up to some pre-market trading levels. The company received a complete response letter from...
Published:
Last Updated:
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) was already on the radar screens in biotech before this morning. But news showing that the company’s cancer drug carfilzomib has received favorable FDA...
Published:
Last Updated:
Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there. After all it was worth some $29.6 billion in market capitalization at Wednesday’s close. Now...
Published:
Last Updated:
We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today. Shares are up nearly 5% at $8.25 and the 12:30 PM trading volume is now over...
Published:
Last Updated:
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares rose after being...
Published:
Last Updated:
ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA’s proposed in...
Published:
Last Updated:
VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some caution for its weight loss pill.The FDA has...
Published:
Last Updated:
Source: Jon OggThere is good news and bad news on Thoratec Corporation (NASDAQ: THOR) today. The bad news is that it did have a FDA news recall of its HeartMate II® Left Ventricular Assist...
Published:
Last Updated:
Thoratec Corporation (NASDAQ: THOR) took it on the chin today after news came out about the Food & Drug Administration recalling the company’s HeartMate II as the left ventricular-assist...
Published:
Last Updated:
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning. News hit that the FDA has now rejected the company’s Northera drug to treat low blood pressure for now in...
Published:
Last Updated:
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front. The companies have announced that the European Commission has now approved its...
Published:
Last Updated:
The Food and Drug Administration approval of the first generic versions of osteoporosis drug Boniva won’t be the end of Roche Holding AG (OTC: RHHBY) for its marketing of Boniva in the United...
Published:
Last Updated:
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) has been one of the top performing stocks of 2012. Not just in emerging pharma and in biotech, but across the board. Now we have some more good news...
Published:
Last Updated:
Instead of admitting that it has, in the past, sold food with too much sodium, salt and sugar, Walmart (NYSE: WMT) has made a public relations bonanza of its decision to sell more healthy food. The...
Published:
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of the statin drug competitors....
Published: